Circulating bactericidal/permeability-increasing protein (BPI) is associated with serum lipids and endothelial function

Thrombosis and Haemostasis

Volumn 103, Issue 4, 2010, Pages 780-787

  Esteve, Eduardo ^a,b   Castro, Antoni ^a,b   Moreno, Jose Maria ^a,b   Vendrell, Joan ^c   Ricart, Wifredo ^a,b   Fernández Real, José Manuel ^a,b  

^a GIRONA BIOMEDICAL RESEARCH INSTITUTE IDIBGI   (Spain)

^b INSTITUTO DE SALUD CARLOS III   (Spain)

^c HOSPITAL UNIVERSITARI JOAN XXIII   (Spain)

Author keywords

Bactericidal permeability increasing protein; Cholesteryl ester transfer protein; Cytokines; HDL cholesterol; Infection; Inflammation

Indexed keywords

CELL PROTEIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PROTEIN BPI; UNCLASSIFIED DRUG;

ADULT; ANTHROPOMETRY; ARTICLE; BLOOD VESSEL REACTIVITY; BODY MASS; CELL FUNCTION; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; ENDOTHELIUM CELL; ENZYME LINKED IMMUNOSORBENT ASSAY; GLUCOSE TOLERANCE; HUMAN; HUMAN EXPERIMENT; LIPID BLOOD LEVEL; MALE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; VASODILATATION;

ADULT; AGED; ANTIMICROBIAL CATIONIC PEPTIDES; BIOLOGICAL MARKERS; BLOOD GLUCOSE; BLOOD PROTEINS; BRACHIAL ARTERY; ENDOTHELIUM, VASCULAR; ENZYME-LINKED IMMUNOSORBENT ASSAY; EUROPEAN CONTINENTAL ANCESTRY GROUP; GLUCOSE TOLERANCE TEST; HUMANS; LINEAR MODELS; LIPIDS; MALE; MIDDLE AGED; SPAIN; VASODILATION;

EID: 77952084800     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1160/TH09-08-0596     Document Type: Article

References (28)

1. Schatz IJ, Masaki K, Yano K, et al. Cholesterol and all-cause mortality in elderly people from the Honolulu Heart Program: a cohort study. Lancet 2001; 358: 351-355. (Pubitemid 32739094)
2. Jacobs DR, Blackburn H, Higgins M, et al. Report of the conference on low blood cholesterol: mortality associations. Circulation 1992; 86: 1046-1060.
3. Iribarren C, Reed DM, Chen R, et al. Low serum cholesterol and mortality. Which is the cause and which is the effect? Circulation 1995; 92: 2396-2403.
4. Meilahn EN. Low serum cholesterol. Hazardous to health? Circulation 1995; 92: 2365-2366.
5. Bingle CD, Craven CJ. Meet the relatives: a family of BPI- and LBP-related proteins. Trends Immunol 2004; 25: 53-55.
6. Weiss J, Olsson I. Cellular and subcellular localization of the bactericidal/ permeability-increasing protein of neutrophils. Blood 1987; 69: 652-659. (Pubitemid 17022043)
7. Elsbach P. The bactericidal/permeability-increasing protein (BPI) in antibacterial host defense. J Leukoc Biol 1998; 64: 14-18. (Pubitemid 28304668)
8. Beamer LJ, Carroll SF, Eisenberg D. Crystal structure of human BPI and two bound phospholipids at 2.4 Angstrom resolution. Science 1997; 276: 1861-1864. (Pubitemid 27443663)
9. Megia A, Gallart L, Fernández-Real JM, et al. Mannose-binding lectin gene polymorphism is associated with gestational diabetes mellitus. J Clin Endocrinol Metab 2004; 89: 5081-5087. (Pubitemid 39391452)
10. Fernández-Real JM, Broch M, Richart C, et al. CD14 monocyte receptor, involved in the inflammatory cascade, and insulin sensitivity. J Clin Endocrinol Metab 2003; 88: 1780-1784. (Pubitemid 36623404)
11. Chen Z, Peto R, Collins R, et al. Serum cholesterol concentration and coronary heart disease in populations with low cholesterol concentrations. Br Med J 1993; 303: 276-282.
12. Chien JY, Jerng JS, Yu CJ, et al. Low serum level of high-density lipoprotein cholesterol is a poor prognostic factor for severe sepsis. Crit. Care Med 2005; 33: 1688-1693. (Pubitemid 41153691)
13. Vermont CL, den Brinker M, Kakeci N, et al. Serum lipids and disease severity in children with severe meningococcal sepsis. Crit Care Med 2005; 33: 1610-1615. (Pubitemid 40980620)
14. Schultz H, Heintz H, van Zandbergen G, et al. ANCA against the bactericidal/permeability increasing protein (BPI-ANCA) can compromise the antibiotic function of BPI in a Wegener's granulomatosis patient. Clin. Exp. Rheumatol 2003; 21: 763-1736
15. Alexander S, Bramson J, Foley R, et al. Protection from endotoxemia by adenoviral- mediated gene transfer of human bactericidal/permeability-increasing protein. Blood 2004; 103: 93-99. (Pubitemid 38029923)
16. Wong HR, Doughty LA, Wedel N, et al. JA. Plasma bactericidal/ permeability-increasing protein concentrations in critically ill children with the sepsis syndrome. J Pediatr Infect Dis 1995; 14: 1087-1091. (Pubitemid 26008462)
17. Fernandez-Real JM, Ricart W. Cholesterol and all-cause mortality in Honolulu. Lancet 2001; 358: 1906-1907.
18. ForetteB, Tortrat D, Wolmark Y. Cholesterol as a risk factor for mortality in elderly women. Lancet 1989; 1: 868-870. (Pubitemid 19107876)
19. Harris HW, Grunfeld C, Feingold KR, et al. Human very low density lipoproteins and chylomicrons can protect against endotoxin-induced death in mice. J Clin Invest 1990; 86: 696-702. (Pubitemid 20327356)
20. Vreugdenhil ACE, Snoek AMP, van't Veer C, et al. LPS-binding protein circulates in associaiton with apo-B containing lipoproteins and enhances endotoxin-LDL/VLDL interaction. J Clin Invest 2001; 107: 225-234.
21. Gubern C, López-Bermejo A, Biarnés J, et al. Natural antibiotics and insulin sensitivity: the role of bactericidal/permeability- increasing protein. Diabetes 2006; 55: 216-224. (Pubitemid 43343318)
22. Weiss J, Elsbach P, Shu C, et al. Human bactericidal/permeability- increasing protein and a recombinant NH2-terminal fragment cause killing of serum-resistant gram-negative bacteria in whole blood and inhibit tumor necrosis factor release induced by the bacteria. J Clin Invest 1992; 90: 1122-1130.
23. Arditi M, Zhou J, Huang SH, et al. Bactericidal/permeability-increasing protein protects vascular endothelial cells from lipopolysaccharide-induced activation and injury. Infect Immun 1994; 62: 3930-3936. (Pubitemid 24264339)
24. Van der Schaft DW, Toebes EA, Haseman JR, et al. Bactericidal/ permeability-increasing protein (BPI) inhibits angiogenesis via induction of apoptosis in vascular endothelial cells. Blood 2000; 96: 176-181.
25. Ciornei CD, Egesten A, Engström M et al. Bactericidal/permeability- increasing protein inhibits endotoxin-induced vascular nitric oxide synthesis. Acta Anaesthesiol Scand 2002; 46: 1111-1118.
26. Hardardottir I, Moser AH, Fuller J, et al. Endotoxin and cytokines decrease serum levels and extra hepatic protein and mRNA levels of cholesteryl ester transfer protein in syrian hamsters. J Clin Invest 1996; 97: 2585-2592. (Pubitemid 26187346)
27. Jiang XC, Bruce C. Regulation of murine plasma phospholipid transfer protein activity and mRNA levels by lipopolysaccharide and high cholesterol diet. J Biol Chem 1995; 270: 17133-17138.
28. Jiang XC, Bruce C, Mar J, et al. Targeted mutation of plasma phospholipid transfer protein gene markedly reduces high-density lipoprotein levels. J Clin Invest 1999; 103: 907-914. (Pubitemid 29152637)